We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Pertinax Pharma

We currently have no video available for this pitch.

Infections can be reduced and patient quality of life can be improved by using antimicrobial wound care materials developed by Pertinax. In vitro studies have already been performed using the company's development across multiple applications.

  • £616,916
    raised of £699,997 goal
  • Active
    04 Jul 2018
  • 18
  • 28.00%
    equity offered
  • £1,799,992
    pre-money valuation
  • Syndicate Room
  • Medical EIS
View on Syndicate Room businessagent.com may earn a commission from partners

The content below is news from around the world relating to @PertinaxPharma

The below content is from social media taken from external sites and is not representative of the views of businessagent.com or Pertinax Pharma.

Twitter feed: @PertinaxPharma

Please sign in or register to businessagent.com to comment on this pitch.

Sign In Register

Other pitches in Medical

  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph